MedicationDosage*FormulationCommentsCost
Histamine H2receptor antagonists
  • Cimetidine

  • Neonates: 5 to 10 mg per kg per day, divided every 8 to 12 hours

  • Infants: 10 to 20 mg per kg per day, divided every 6 to 12 hours

  • ≤ 12 years: 20 to 40 mg per kg per day, divided every 6 hours

  • > 12 years: 400 mg every 6 hours or 800 mg every 12 hours

  • Oral solution

  • Affects cytochrome P450, vitamin D metabolism, endocrine function

  • Improves symptom scores, reflux index, and histologic and endoscopic findings in infants and children

  • $40 for one 270-mL bottle

  • (300 mg per 5 mL)

  • Famotidine (Pepcid)

  • 0 to 3 months: 0.5 mg per kg per day

  • 3 to 12 months: 0.5 mg per kg twice daily

  • 1 to 16 years: 0.5 mg per kg twice daily

  • Oral suspension

  • Lacks evidence showing effectiveness in infants and children

  • Approved for up to 8 weeks of use in infants and up to 6 weeks of use in adolescents

  • $75 ($180) for one 50-mL bottle (40 mg per 5 mL)

  • Nizatidine (Axid)

  • 6 months to 11 years: 5 to 10 mg per kg per day, divided every 12 hours

  • ≥ 12 years: 150 mg twice daily

  • Oral solution

  • Improves symptom scores in infants; improves reflux index and histologic and endoscopic findings in infants and children

  • $40 ($55) for one 60-mL bottle (15 mg per mL)

  • Ranitidine

  • Infant to 16 years: 5 to 10 mg per kg per day, divided every 12 hours; maximum dosage of 300 mg per day

  • > 16 years: 150 mg twice per day

  • Syrup

  • Most commonly used H2 receptor antagonist

  • No evidence for symptomatic improvement in infants, but has shown symptomatic benefit in children

  • Improves reflux index and histologic and endoscopic findings in infants and children

  • $30 for one 60-mL bottle (15 mg per mL)

Proton pump inhibitors
  • Esomeprazole (Nexium)

  • 1 to 11 years: 10 mg per day

  • ≥ 12 years: 20 mg per day (alternative dosage for infants, children, and adolescents: 0.7 to 3.3 mg per kg per day)

  • Sprinkle contents of capsule onto food

  • Approved for up to 8 weeks of treatment

  • Improves reflux index in infants; no evidence of improvement in symptom scores

  • Improves symptom scores and histologic and endoscopic findings in children

  • $200 ($260) for 30 capsules (20 mg)

  • Lansoprazole (Prevacid)

  • 3 to 12 months: 7.5 mg twice daily or 15 mg per day

  • 1 to 11 years:

  • ≤ 30 kg: 15 mg per day

  • > 30 kg: 30 mg per day

  • ≥ 12 years: 30 mg per day

  • Sprinkle contents of capsule onto food or into juice; disintegrating tablet

  • Improves symptom scores, reflux index, and histologic and endoscopic findings in children

  • No evidence of effectiveness in infants

  • Approved for 12 weeks of use in children and 8 weeks of use in adolescents

  • Well tolerated in children

  • $40 ($350) for 30 capsules (15 mg)

  • $130 ($350) for 30 tablets (15 mg)

  • Omeprazole (Prilosec)

  • Infants: 0.7 mg per kg per day

  • > 1 year and adolescents:

  • 5 to < 10 kg: 5 mg per day

  • 10 to < 20 kg: 10 mg per day

  • ≥ 20 kg: 20 mg per day

  • Sprinkle contents of capsule onto food

  • Improves symptom scores and reflux index in infants and children

  • Risk of respiratory infections in critically ill children

  • $20 ($210) for 30 capsules (10 mg)

  • Rabeprazole (Aciphex)

  • 1 to 11 years:

  • < 15 kg: 5 mg per day

  • ≥ 15 kg: 10 mg per day

  • ≥ 12 years: 20 mg per day

  • Tablet

  • Lacks evidence of effectiveness in infants and children

  • Approved for up to 12 weeks of use in children 1 to 11 years of age

  • Approved for up to 8 weeks of use in children 12 years and older, and in adolescents

  • $40 ($440) for 30 tablets (20 mg)

Prokinetics
  • Bethanechol

  • Children: 0.1 to 0.2 mg per kg per day, divided every 6 to 8 hours; 1 hour before meals

  • Tablet

  • Lacks evidence showing effectiveness in infants and children

  • May induce respiratory bronchospasm

  • $20 for 30 tablets (5 mg)

  • Erythromycin (E.E.S.)

  • 1.5 to 12.5 mg per kg every 6 to 8 hours

  • Oral suspension

  • Lacks evidence showing effectiveness in infants and children

  • No specific dosing recommendations for GERD

  • Associated with hypertrophic pyloric stenosis in infants younger than 6 weeks

  • NA ($325) for one 100-mL bottle (200 mg per mL)

  • Metoclopramide

  • 0.1 to 0.2 mg per kg three to four times per day

  • Oral solution

  • Not recommended for routine treatment of GERD

  • 34% of treated patients have adverse effects (drowsiness, restlessness, rare extrapyramidal symptoms); use is generally not recommended

  • $4 for one 60-mL bottle (5 mg per 5 mL)

Buffering agents
  • Antacids (magnesium or aluminum hydroxide)

  • Not recommended < 12 years; dosing varies depending on antacid

  • Tablet

  • FDA approved for infants (magnesium hydroxide only), children, and adolescents

  • May produce milk alkali syndrome; caution in renal disease

Surface protective agents
  • Sucralfate (Carafate)

  • Dosing not well established; in children, 40 to 80 mg per kg per day divided every 6 hours has been used

  • Tablet; oral suspension

  • Constipation, dizziness, light-headedness

  • $15 ($80) for 30 tablets (1 g)

  • NA ($45) for one 120-mL bottle (1 g per 10 mL)